Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
Constantinescu C, Pasca S, Tat T, Teodorescu P, Vlad C, Iluta S, Dima D, Tomescu D, Scarlatescu E, Tanase A, Sigurjonsson OE, Colita A, Einsele H, Tomuleasa C. Constantinescu C, et al. Among authors: colita a. J Immunother Cancer. 2020 May;8(1):e000742. doi: 10.1136/jitc-2020-000742. J Immunother Cancer. 2020. PMID: 32474415 Free PMC article. Review.
Let's Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia.
Deak D, Pop C, Zimta AA, Jurj A, Ghiaur A, Pasca S, Teodorescu P, Dascalescu A, Antohe I, Ionescu B, Constantinescu C, Onaciu A, Munteanu R, Berindan-Neagoe I, Petrushev B, Turcas C, Iluta S, Selicean C, Zdrenghea M, Tanase A, Danaila C, Colita A, Colita A, Dima D, Coriu D, Einsele H, Tomuleasa C. Deak D, et al. Among authors: colita a. Front Immunol. 2019 Dec 20;10:2856. doi: 10.3389/fimmu.2019.02856. eCollection 2019. Front Immunol. 2019. PMID: 31921126 Free PMC article. Review.
MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.
Sas V, Pasca S, Jurj A, Pop L, Muramatsu H, Ono H, Dima D, Teodorescu P, Iluta S, Turcas C, Onaciu A, Munteanu R, Zimta AA, Blag C, Popa G, von Gamm EDA, Arghirescu S, Serban M, Man S, Marian M, Petrushev B, Berce C, Colita A, Zdrenghea M, Kojima S, Gulei D, Takahashi Y, Tomuleasa C. Sas V, et al. Among authors: colita a. Cell Physiol Biochem. 2020 Oct 3;54(5):994-1012. doi: 10.33594/000000283. Cell Physiol Biochem. 2020. PMID: 33006449 Free article.
Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma.
Deak-Mihaly D, Iluta S, Pasca S, Jitaru C, Roman A, Andries A, Padurariu-Covit M, Petrushev B, Vasilache A, Bojan A, Zdrenghea M, Dascalescu A, Antohe I, Colita A, Colita A, Dima D, Tanase A, Tomuleasa C. Deak-Mihaly D, et al. Among authors: colita a. J Clin Med. 2021 Sep 29;10(19):4483. doi: 10.3390/jcm10194483. J Clin Med. 2021. PMID: 34640501 Free PMC article.
LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation.
Colita A, Colita A, Bumbea H, Croitoru A, Orban C, Lipan LE, Craciun OG, Soare D, Ghimici C, Manolache R, Gelatu I, Vladareanu AM, Pasca S, Teodorescu P, Dima D, Lupu A, Coriu D, Tomuleasa C, Tanase A. Colita A, et al. Front Oncol. 2019 Sep 10;9:892. doi: 10.3389/fonc.2019.00892. eCollection 2019. Front Oncol. 2019. PMID: 31552193 Free PMC article.
Transient leukemia of Down syndrome.
Sas V, Blag C, Zaharie G, Puscas E, Lisencu C, Andronic-Gorcea N, Pasca S, Petrushev B, Chis I, Marian M, Dima D, Teodorescu P, Iluta S, Zdrenghea M, Berindan-Neagoe I, Popa G, Man S, Colita A, Stefan C, Kojima S, Tomuleasa C. Sas V, et al. Among authors: colita a. Crit Rev Clin Lab Sci. 2019 Jun;56(4):247-259. doi: 10.1080/10408363.2019.1613629. Epub 2019 Jun 21. Crit Rev Clin Lab Sci. 2019. PMID: 31043105 Review.
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome.
Moisoiu V, Sas V, Stefancu A, Iancu SD, Jurj A, Pasca S, Iluta S, Zimta AA, Tigu AB, Teodorescu P, Turcas C, Blag C, Dima D, Popa G, Arghirescu S, Man S, Colita A, Leopold N, Tomuleasa C. Moisoiu V, et al. Among authors: colita a. Front Bioeng Biotechnol. 2021 Jul 23;9:703268. doi: 10.3389/fbioe.2021.703268. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34368097 Free PMC article.
Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases.
Radu LE, Colita A, Pasca S, Tomuleasa C, Popa C, Serban C, Gheorghe A, Serbanica A, Jercan C, Marcu A, Bica A, Teodorescu P, Constantinescu C, Petrushev B, Asan M, Jardan C, Dragomir M, Tanase A, Colita A. Radu LE, et al. Among authors: colita a. Front Oncol. 2020 Jun 30;10:923. doi: 10.3389/fonc.2020.00923. eCollection 2020. Front Oncol. 2020. PMID: 32695667 Free PMC article.
115 results